December 2, 2016 3:58 pm
Heather Bresch came to the fifth annual Forbes Healthcare conference to talk about the fallout from the EpiPen pricing controversy.
November 30, 2016 8:32 am
This condition produces mutations that lead to a serious shortage of white blood cells.
November 30, 2016 9:46 am
The myelofibrosis market is expected to almost double in value from $545.2 million in 2015 to $1.02 billion by 2025, representing a compound annual growth rate of 6.4%.
November 29, 2016 9:58 am
Approximately 400,000 people all over the world are living with either hemophilia A or hemophilia B.
November 28, 2016 12:00 pm
North America remains the largest regional market for drug delivery technologies, with the US accounting for the largest market in terms of value and volume.
November 28, 2016 8:50 am
An experimental Alzheimer’s drug being developed by Eli Lilly failed to slow cognitive decline in patients with even a mild form of the condition.
November 22, 2016 9:57 am
Generic penetration is currently non-existent in the cancer vaccines market, further aiding market growth.
November 21, 2016 4:02 pm
Novartis is boosting its hematology pipeline with a new acquisition.
November 21, 2016 8:26 am
More people died from drug overdose in 2014 than in any other year, and six in 10 of those deaths involved an opioid, such as a painkiller or heroin.
November 17, 2016 10:01 am
Amgen and Novartis are one step closer to having a contender in the migraine treatment space.
- 1 of 5
- next ›